Impact of technology overlapping: A case study on colorectal cancer screening

Technology and Health Care

Volumn 18, Issue 4-5, 2010, Pages 303-315

  Di Bidino, Rossella ^a   Cicchetti, Americo ^b   Corio, Mirella ^a   Polisena, Julie ^c   Oradei, Marco ^a   Marchetti, Marco ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c CANADIAN AGENCY FOR DRUGS AND TECHNOLOGIES IN HEALTH   (Canada)

Author keywords

Colorectal cancer; health policy; Incremental Cost Effectiveness Ratio; Semi Markov model; Technology overlapping

Indexed keywords

ARTICLE; ATTITUDE TO HEALTH; COLONOSCOPY; COLORECTAL TUMOR; COST BENEFIT ANALYSIS; EARLY DIAGNOSIS; ECONOMICS; HUMAN; METHODOLOGY; MIDDLE AGED; OCCULT BLOOD; PROBABILITY; QUALITY OF LIFE;

COLONOSCOPY; COLORECTAL NEOPLASMS; COST-BENEFIT ANALYSIS; EARLY DETECTION OF CANCER; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MARKOV CHAINS; MIDDLE AGED; OCCULT BLOOD; QUALITY OF LIFE;

EID: 78649520244     PISSN: 09287329     EISSN: None     Source Type: Journal    
DOI: 10.3233/THC-2010-0594     Document Type: Article

References (44)

1. Advisory Committee On Cancer Prevention. Recommendations on cancer screening in the European Union. Conference on screening and early screening of cancer Vienna 18th - 19th November 1999. Available on: http://ec.europa.eu/ health/phdeterminants/genetics/cancer screeningen.pdf [Access online 01 April 2010].
2. C. Berchi, V. Bouvier, J.M. Réaud and G. Launoy, Costeffectiveness analysis of two strategies for mass screening for colorectal cancer in France, Health Economics 13 (2004), 227-238.
3. T. Bodenheimer, High and Rising Health Care Cost, Part 2: Technologic Innovation, Annals of Internal Medicine 142 (2005), 932-937.
4. F. Borie, C. Combescure, J.P.Daurès, B. Trétarre and B.Millat, Costeffectiveness of two followup strategies for curative resection of colorectal cancer: comparative study using a markov model, World J Surg 28 (2004), 563-569.
5. F.Borie, J.P.Daurès, B.Millat and B. Trétarre, Cost and effectiveness of followup examinations in patients with colorectal cancer resected for curein a French populationbased study, Journal of Gastrointestinal Surgery 8(5) (2004), 552-558.
6. C. Catananti, A. Cicchetti and M. Marchetti, Overlapping delle tecnologie e i processi di sostituzione tecnologica in sanità. Convegno nazionale Associazione Italiana di Economia Sanitaria, Tor Vergata Roma, 2003.
7. L. Ciccolallo, R. Capocaccia,M.P. Coleman et al., Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgery, Gut 54(2) (2005), 268-273.
8. C. Claxton, The innovators dilemma: when new technologies cause great firms to fail, Harvard Business Press, 1997.
9. D.M. Cutler and M. McCellan, Is Technological Change in Medicine Worth It? Health Affairs 20 (2001), 11-29.
10. A. Donatini, A. Rico, M.G. DAmbrosio et al., Health Care System in Transiction, Italy. European Observatory on Health Care Systems, 2001.
11. Epicentro -National Center of Epidemiology, Surveillance and Health Promotion. Prevention National Plan (2005-2007). Colorectal Cancer Sceening: Regional Scenario. Available here: http://www.epicentro.iss.it/focus/piano prevenzione/screening regioni. asp [Access online 01 April 2010].
12. R. Etzioni, S.D. Ramsey, K. Berry and M. Brown, The impact of including future medical costs when estimating the cost attributable to a disease: a colorectal cancer case study, Health Economics 10 (2001), 245-256.
13. EUCOMED. Eucomed position paper on Health Technology Assessment (HTA). June 2008. Available on: http://www.eucomed.org/press//media/ 49C306A47FE1424CBCA8ADC185F62554.ashx [Access online on 01 April 2010].
14. EUnetHTA. HTA Definition. Available on: http://www.eunethta.net/Public/ HTA/ [Access online on 01 April 2010].
15. European Group for Colorectal Cancer Screening, Recommendation to include colorectal cancer screening in public health policy, Journal of Medical Screening 6 (1999), 80-81.
16. A.Federici, P. Giorgi Rossi, F. Bartolozzi, S. Farchi, P. Borgia and G. Guasticchi, Survey on colorectal cancer screening knowledge, attitudes, and practices of general practice physicians in Lazio, Italy, Preventive Medicine 41(1) (2005), 30-35.
17. G. France, F. Taroni and A. Donatini, The Italian healthcare system, Health Economics 14 (2005), S187-S202.
18. A.L.Frazier, G.A. Colditz, C.S. Fuchs and K.M. Kuntz, Costeffectiveness of screening for colorectal cancer in general population, JAMA 284(15) (2000), 1954-1961.
19. A, Gelijns and N. Rosenberg, The Dynamics of Technological Change in Medicine, Health Affairs 13(3) (1994), 28-46.
20. GISCoR - Gruppo Italiano Screening Colon Rettale. Programmi di screening (Screening programs in Italy). Available on: http://www.giscor.it/screening/ screening.htm [Access online 01 April 2010].
21. ISTAT. DemoGeodemo. Demografia in cifre. Available on: http://demo.istat.it/ [Access online 01 April 2010].
22. C.N. Klabunde, E. Jones, M.L. Brown and W.W. Davis, Colorectal cancer screening with doublecontrast barium enema: a national survey of diagnostic radiologists, American Journal of Roentgenology 179 (2002), 1419-1427.
23. U. Ladabaum and K. Song, Projected national impact of colorectal cancer screening on clinical and economic outcomes and health service demand, Gastroenterology 129 (2005), 1151-1162.
24. J.D. Lewis, A.Brown, R.Localio and S. Schwartz, Initial evaluation of rectal bleeding in young persons: a costeffectiveness analysis, Ann Intern Med 136 (2002), 99-110.
25. J. Lubitz, Health, Technology, And Medical Care Spending, Health Affairs (Millwood) 0 (2005), 5811.
26. Ministero della Salute, Progetto Mattoni. Mattone 2. Classificazione delle prestazioni ambulatoriali, 2006. Available on: http://www.nsis. ministerosalute.it/mattoni/documenti/1.5.6 Contenuti informativi per la rilevazione delle prestazioni.pdf [Access online on 01 April 2010].
27. R.M. Ness, A.M. Holmes, R. Klein and R. Dittus, Utility valuations for outcome states of colorectal cancer, American Journal of Gastroenterology 94(6) (1999), 1650-1657.
28. J.P. Newhouse, An Iconoclastic View of Health Cost Containment, Health Affairs (Millwood) 12 (1993), 152-171.
29. B.A. OLeary, J.K. Olynyk, A.M. Neville and C.F. Platell, Costeffectiveness of colorectal cancer screening: comparison of communitybased flexible sigmoidoscopy with faecal occult blood testing and colonoscopy, Journal of Gastroenterology and Hepatology 19 (2004), 38-47.
30. N. Philips and A.J. Coldman, Computer simulation of the effect of different colorectal cancer screening strategies for British Columbia, British Columbia Medical Journal 45(6) (2003), 254-258.
31. S.D. Ramsey, M.R. Andersen, R. Etzioni et al., Quality of life in survivors of colorectal carcinoma, Cancer 88(6) (2000), 1294-1303.
32. M.D. Rawlings and A.J. Culyer, National Institute of Clinical Excellence and its value judgements, British Medical Journal 329 (2004), 224-226.
33. T.E. Read and I.J. Kodner, Colorectal Cancer: Risk Factors and Recommendations for Early Screening, American Family Physician 59(11) (1999), 2979-2980.
34. D.K. Rex, A.J. David, J.C. Anderson, P.S. Schoenfeld, C.A. Burke and J.M. Inadomi, American College of Gastroenterology Guidelines for Colorectal Cancer Screening 2008, American Journal of Gastroenterology 104 (2009), 739-750.
35. N. Segnan, C. Senore, B. Andreoni et al., Baseline findings of the Italian multicenter randomized controlled trial of onceonly sigmoidoscopySCORE, Journal of the National Cancer Institute 94(23) (2002), 1763-1772.
36. N. Segnan, C. Senore, B. Andreoni et al., Randomized trial of different screening strategies for colorectal cancer: patient response and screening rates, Journal of the National Cancer Institute 97(5) (2005), 347-357.
37. Servizio Sanitario Regionale, Emilia Romagna,Una neoplasia che è possibile prevenire. Il Cancro del Colon Retto, Available on: http://www.ospfe.it/index.phtml?id=142 [Accessed the 01 April 2010]
38. V.K. Sharma, R. Vasudeva and C.W. Howden, Colorectal cancer screening and surveillance practices by primary care physicians: results of a national survey, The American Journal of Gastroenterology 95(6) (2000), 1551-1556.
39. U.S. Preventive Services Task Force, Screening for Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement, Annals of Internal Medicine 149 (2008), 627-637.
40. F.A. Sonnerberg and J.R. Beck,Markov models in medical decision making: a practical guide, Medical DecisionMaking 13 (1993), 322-339.
41. D.K. Whynes, A.R. Neilson, M.H.E. Robinson and J.D. Hardcastle, Colorectal cancer screening and quality of life, Quality of Life Research 3(3) (1994), 191-198.
42. S. Winawer, R. Fletcher, D. Rex et al., Colorectal cancer screening and surveillance: clinical guidelines and rationaleUpdate based on new evidence, Gastroenterology 124 (2003), 544-560.
43. World Health Organization. Medical Device Regulations: Global Overview and Guiding Principles, 2003.
44. G.H.M. Wu, W.M. Wang, A.M.F. Yen et al., Costeffectiveness of colorectal cancer screening with stool DNA testing in intermediateincidence countries, BMC Cancer 6 (2006), 136.